Continuum Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Continuum Advisory's REGN Position: Q2 2026 in Review
Continuum Advisory opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 73 shares worth $45.5K. The stake represents ﹤0.01% of the portfolio and ranks #812 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in REGN as recently as Q1 2025.
Continuum Advisory first reported a position in REGN in Q3 2024 and has held it in 4 quarters since. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Continuum Advisory held 73 shares of Regeneron Pharmaceuticals worth $45.5K as of Q2 2026.
- Regeneron Pharmaceuticals was a new Continuum Advisory position in Q2 2026.
- Regeneron Pharmaceuticals made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #812 holding.
- Continuum Advisory first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
- 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.